skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A large scale study of angiotensin II inhibition therapy in an elderly population: the CHANCE study

(2439) Views  (355) Full article downloads

Authors: Roland Asmar, Sophie Nisse-Durgeat

Published Date January 2006 Volume 2006:2(3) Pages 317 - 323
DOI: http://dx.doi.org/10.2147/VHRM.S

Roland Asmar1, Sophie Nisse-Durgeat2

1The Cardiovascular Institute, Paris, France; 2Laboratoire Takeda, Puteaux, France

Abstract: This 8-week, multicenter study evaluated the efficacy and safety of candesartan cilexetil (CC, 8–16 mg) in elderly (>65 years) hypertensive patients. Patients (n=3013) received CC 8 mg during 8 weeks which eventually doubled to CC 16 mg at week 4 if blood pressure remained uncontrolled (>140/90 mmHg). At week 8, 65.5% of patients were normalized (BP <140/90 mmHg). Mean changes at week 8 were –25.8, –13.2, and –12.7 mmHg for systolic, diastolic, and pulse pressure, respectively. Age, sex, and diabetic status did not influence the antihypertensive effect of CC. 68% of the patients treated with, but uncontrolled or intolerant of, prior antihypertensive treatment were normalized by CC 8–16 mg. In summary, CC 8– 16 mg once daily was effective and well tolerated in the management of arterial hypertension in elderly subjects.

Keywords: candesartan cilexetil, angiotensin II receptor antagonist, hypertension, elderly subject, CHANCE study








Readers of this article also read:

A review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levels
Metabolic syndrome: the danger signal in atherosclerosis
Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment
Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects
Erratum
Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: Comparison with high cardiovascular risk population
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
Editorial
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University